Impact on clinical practice of updated guidelines on iodinated contrast material: CINART

被引:12
|
作者
Nijssen, E. C. [1 ]
Nelemans, P. J. [2 ]
Rennenberg, R. J. [3 ]
van der Molen, A. J. [4 ]
van Ommen, G. V. [5 ]
Wildberger, J. E. [1 ]
机构
[1] Maastricht Univ, Med Ctr, Dept Radiol & Nucl Med, POB 5800, NL-6202 AZ Maastricht, Netherlands
[2] Maastricht Univ, Dept Epidmiol, POB 616, NL-6200 MD Maastricht, Netherlands
[3] Maastricht Univ, Dept Internal Med, Med Ctr, POB 5800, NL-6202 AZ Maastricht, Netherlands
[4] Leiden Univ, Dept Radiol, Med Ctr, Postal Zone C-2S, NL-2333 ZA Leiden, Netherlands
[5] Maastricht Univ, Dept Cardiol, Med Ctr, POB 5800, NL-6202 AZ Maastricht, Netherlands
关键词
Clinical practice guideline; Contrast media; Preventive measures; Acute kidney injury; Costs and cost analysis; ACUTE KIDNEY INJURY; RISK; PREVENTION; HYDRATION; MEDIA;
D O I
10.1007/s00330-020-06719-7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective Guidelines on safe use of iodinated contrast material recommend intravenous prophylactic hydration to prevent post-contrast adverse (renal) effects. Recently, guidelines have been updated and standard prophylaxis is no longer recommended for the majority of patients. The current study aims to evaluate the consequences for clinical practice of the updated guidelines in terms of complications, hospitalisations, and costs. Methods The Contrast-Induced Nephropathy After Reduction of the prophylaxis Threshold (CINART) project is a retrospective observational study. All elective procedures with intravascular iodinated contrast administration at Maastricht University Medical Centre (UMC+) in patients aged > 18 years, formerly eligible for prophylaxis (eGFR 30-44 ml/min/1.73 m(2) or eGFR 45-59 ml/min/1.73 m(2) in combination with diabetes or > 1 predefined risk factor), and currently eligible for prophylaxis (eGFR < 30 ml/min/1.73 m(2)) were included. Data were used to calculate relative reductions in complications, hospitalisations, and costs associated with standard prophylactic intravenous hydration. CINART is registered with : NCT03227835. Results Between July 1, 2017, and July 1, 2018, 1992 elective procedures with intravascular iodinated contrast in patients formerly and currently eligible for prophylaxis were identified: 1808 in patients formerly eligible for prophylaxis and 184 in patients currently eligible for prophylaxis. At Maastricht UMC+, guideline updates led to large relative reductions in numbers of complications of prophylaxis (e.g. symptomatic heart failure; - 89%), extra hospitalisations (- 93%), and costs (- 91%). Conclusion Guideline updates have had a demonstrable impact on daily clinical practice benefiting patient, hospital, and health care budgets. Clinical practice varies between institutions and countries; therefore, a local estimation model is provided with which local impact on costs, hospitalisations, and complications can be calculated.
引用
收藏
页码:4005 / 4013
页数:9
相关论文
共 50 条
  • [1] Impact on clinical practice of updated guidelines on iodinated contrast material: CINART
    E. C. Nijssen
    P. J. Nelemans
    R. J. Rennenberg
    A. J. van der Molen
    G. V. van Ommen
    J. E. Wildberger
    European Radiology, 2020, 30 : 4005 - 4013
  • [2] Evaluation of Safety Guidelines on the Use of Iodinated Contrast Material Conundrum Continued
    Nijssen, Estelle C.
    Nelemans, Patty J.
    Rennenberg, Roger J.
    van Ommen, Vincent
    Wildberger, Joachim E.
    INVESTIGATIVE RADIOLOGY, 2018, 53 (10) : 616 - 622
  • [3] Updated clinical practice guidelines on pregnancy care
    Homer, Caroline S. E.
    Oats, Jeremy
    Middleton, Philippa
    Ramson, Jenny
    Diplock, Samantha
    MEDICAL JOURNAL OF AUSTRALIA, 2018, 209 (09) : 409 - +
  • [4] Secondary prevention in theory and practice: the impact of updated guidelines
    Anselmino, M.
    Ohrvik, J.
    Ryden, L.
    EUROPEAN HEART JOURNAL, 2008, 29 : 140 - 140
  • [5] Impact of Updated Clinical Practice Guidelines on Outpatient Treatment for Clostridioides difficile Infection and Associated Clinical Outcomes
    Dubberke, Erik R.
    Puckett, Justin T.
    Obi, Engels N.
    Kamal-Bahl, Sachin
    Desai, Kaushal
    Stuart, Bruce
    Doshi, Jalpa A.
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (10):
  • [6] Updated clinical practice guidelines for the prevention and treatment of mucositis
    Keefe, Dorothy M.
    Schubert, Mark M.
    Elting, Linda S.
    Sonis, Stephen T.
    Epstein, Joel B.
    Raber-Durlacher, Judith E.
    Migliorati, Cesar A.
    McGuire, Deborah B.
    Hutchins, Ronald D.
    Peterson, Douglas E.
    CANCER, 2007, 109 (05) : 820 - 831
  • [7] A new treatment and updated clinical practice guidelines for MASLD
    Powell, Elizabeth E.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2025, 22 (02) : 88 - 89
  • [8] Updated clinical practice guidelines for the prevention and treatment of mucositis
    Bensadoun, R. -J.
    Proceedings of the 6th International Congress of the World Association of Laser Therapy, 2006, : 69 - 73
  • [9] Perfusion CT with iodinated contrast material
    Eastwood, JD
    Lev, MH
    Provenzale, JM
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2003, 180 (01) : 3 - 12
  • [10] ANAPHYLACTOID REACTIONS TO IODINATED CONTRAST MATERIAL
    LIEBERMAN, P
    SIEGLE, RL
    TAYLOR, WW
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1978, 62 (03) : 174 - 180